{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:35:38Z","timestamp":1791898538675,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000531"],"award-info":[{"award-number":["82000531"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360118"],"award-info":[{"award-number":["82360118"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013064","name":"Key Research and Development Program of Jiangxi Province","doi-asserted-by":"publisher","award":["20212BBG73018"],"award-info":[{"award-number":["20212BBG73018"]}],"id":[{"id":"10.13039\/501100013064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003397","name":"Huazhong University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012259","name":"Major Discipline Academic and Technical Leaders Training Program of Jiangxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016817","name":"University of Maryland School of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004637","name":"Nanchang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Microbe"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.lanmic.2024.100975","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T15:17:20Z","timestamp":1734535040000},"page":"100975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Effects of amoxicillin dosage on cure rate, gut microbiota, and\u00a0antibiotic resistome in vonoprazan and amoxicillin dual therapy for Helicobacter pylori: a multicentre, open-label, non-inferiority randomised controlled trial"],"prefix":"10.1016","volume":"6","author":[{"given":"Yi","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Zhen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Kui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Y W","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4261-6888","authenticated-orcid":false,"given":"Yi-Qi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Y","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nong-Hua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanmic.2024.100975_bib1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S2468-1253(23)00070-5","article-title":"Global prevalence of Helicobacter pylori infection between 1980\u00a0and 2022: a\u00a0systematic review and meta-analysis","volume":"8","author":"Li","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.lanmic.2024.100975_bib2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1053\/j.gastro.2023.12.022","article-title":"Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980\u00a0and 2022","volume":"166","author":"Chen","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lanmic.2024.100975_bib3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/gutjnl-2022-328965","article-title":"Large-scale, national, family-based epidemiological study on Helicobacter pylori infection in China: the time to change practice for related disease prevention","volume":"72","author":"Zhou","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.lanmic.2024.100975_bib4","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1136\/gutjnl-2020-322368","article-title":"Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus","volume":"69","author":"Liou","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.lanmic.2024.100975_bib5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/gutjnl-2019-319954","article-title":"Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan","volume":"69","author":"Suzuki","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.lanmic.2024.100975_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2468-1253(23)00281-9","article-title":"Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990\u00a0and 2022: an updated systematic review and meta-analysis","volume":"9","author":"Hong","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.lanmic.2024.100975_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.lanmic.2024.100975_bib8","article-title":"Optimization of vonoprazan-amoxicillin dual therapy for eradicating Helicobacter pylori infection in China: a prospective, randomized clinical pilot study","volume":"27","author":"Hu","year":"2022","journal-title":"Helicobacter"},{"key":"10.1016\/j.lanmic.2024.100975_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1049908","article-title":"Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating Helicobacter pylori infection: a prospective, open-labeled, randomized non-inferiority clinical study","volume":"13","author":"Hu","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.lanmic.2024.100975_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13045","article-title":"Vonoprazan and amoxicillin dual therapy for 14\u00a0days as the first-line treatment of Helicobacter pylori infection: a non-inferiority, randomized clinical trial","volume":"29","author":"Hu","year":"2024","journal-title":"Helicobacter"},{"key":"10.1016\/j.lanmic.2024.100975_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.14309\/ajg.0000000000002592","article-title":"Ten-day vonoprazan-amoxicillin dual therapy vs standard 14-day bismuth-based quadruple therapy for first-line Helicobacter pylori eradication: a multicenter randomized clinical trial","volume":"119","author":"Yan","year":"2024","journal-title":"Am J\u00a0Gastroenterol"},{"key":"10.1016\/j.lanmic.2024.100975_bib12","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.cgh.2024.01.022","article-title":"Efficacy and safety of vonoprazan-amoxicillin dual regimen with varying dose and duration for Helicobacter pylori eradication: a multicenter, prospective, randomized study","volume":"22","author":"Peng","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.lanmic.2024.100975_bib13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1053\/j.gastro.2022.05.055","article-title":"Vonoprazan triple and dual therapy for Helicobacter pylori infection in the United States and Europe: randomized clinical trial","volume":"163","author":"Chey","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lanmic.2024.100975_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12830","article-title":"Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections\u2014exploratory study","volume":"26","author":"Gunaratne","year":"2021","journal-title":"Helicobacter"},{"key":"10.1016\/j.lanmic.2024.100975_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S2468-1253(22)00384-3","article-title":"Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial","volume":"8","author":"Liou","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.lanmic.2024.100975_bib16","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2157200","article-title":"Differential response to prolonged amoxicillin treatment: long-term resilience of the microbiome versus long-lasting perturbations in the gut resistome","volume":"15","author":"Dhariwal","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.lanmic.2024.100975_bib17","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/jgh.15917","article-title":"Amoxicillin-vonoprazan dual therapy for Helicobacter pylori eradication: a systematic review and meta-analysis","volume":"37","author":"Ouyang","year":"2022","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.lanmic.2024.100975_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13039","article-title":"Vonoprazan and amoxicillin dual\u00a0therapy as the first-line treatment of Helicobacter pylori infection: a systematic review and meta-analysis","volume":"29","author":"Du","year":"2024","journal-title":"Helicobacter"},{"key":"10.1016\/j.lanmic.2024.100975_bib19","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cgh.2021.03.026","article-title":"Primer for development of guidelines for Helicobacter pylori therapy using antimicrobial stewardship","volume":"20","author":"Graham","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.lanmic.2024.100975_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13012","article-title":"Research trends on vonoprazan-based therapy for Helicobacter pylori eradication: a bibliometric analysis from 2015\u00a0to 2023","volume":"28","author":"Du","year":"2023","journal-title":"Helicobacter"},{"key":"10.1016\/j.lanmic.2024.100975_bib21","doi-asserted-by":"crossref","first-page":"780.e5","DOI":"10.1016\/j.cmi.2017.11.010","article-title":"Primary antibiotic resistance of Helicobacter pylori in Chinese patients: a multiregion prospective 7-year study","volume":"24","author":"Liu","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.lanmic.2024.100975_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13756-019-0632-1","article-title":"Characteristics of Helicobacter pylori antibiotic resistance: data from four different populations","volume":"8","author":"Liu","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.lanmic.2024.100975_bib23","first-page":"5027","article-title":"A\u00a0retrospective study of the antibiotic-resistant phenotypes and genotypes of Helicobacter pylori strains in China","volume":"11","author":"Zhong","year":"2021","journal-title":"Am J\u00a0Cancer Res"},{"key":"10.1016\/j.lanmic.2024.100975_bib24","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/apt.13588","article-title":"Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype","volume":"43","author":"Kagami","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.lanmic.2024.100975_bib25","doi-asserted-by":"crossref","first-page":"JC54","DOI":"10.7326\/J23-0028","article-title":"H\u00a0pylori infection, vonoprazan plus high-dose amoxicillin was noninferior to B-quadruple therapy for eradication","volume":"176","author":"Flynn","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lanmic.2024.100975_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1909459","article-title":"The\u00a0interplay between Helicobacter pylori and gastrointestinal microbiota","volume":"13","author":"Chen","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.lanmic.2024.100975_bib27","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S1473-3099(19)30272-5","article-title":"Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial","volume":"19","author":"Liou","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2024.100975_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.881968","article-title":"Altered gut microbiota and short-chain fatty acids after vonoprazan-amoxicillin dual therapy for\u00a0Helicobacter pylori eradication","volume":"12","author":"Hu","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.lanmic.2024.100975_bib29","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1053\/j.gastro.2020.06.100","article-title":"Effects of intestinal fungi and viruses on immune responses and inflammatory bowel diseases","volume":"160","author":"Iliev","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lanmic.2024.100975_bib30","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1038\/s41467-023-37975-y","article-title":"Altered human gut virome in patients undergoing antibiotics therapy for Helicobacter pylori","volume":"14","author":"Wang","year":"2023","journal-title":"Nat Commun"}],"container-title":["The Lancet Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524724002362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524724002362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T21:51:41Z","timestamp":1762638701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666524724002362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2666524724002362"],"URL":"https:\/\/doi.org\/10.1016\/j.lanmic.2024.100975","relation":{},"ISSN":["2666-5247"],"issn-type":[{"value":"2666-5247","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of amoxicillin dosage on cure rate, gut microbiota, and\u00a0antibiotic resistome in vonoprazan and amoxicillin dual therapy for Helicobacter pylori: a multicentre, open-label, non-inferiority randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanmic.2024.100975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100975"}}